HomeGUD • TSE
add
Knight Therapeutics Inc
Nakaraang pagsara
$6.19
Sakop ng araw
$6.08 - $6.19
Sakop ng taon
$5.43 - $6.57
Market cap
598.50M CAD
Average na Volume
122.34K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 121.55M | 31.74% |
Gastos sa pagpapatakbo | 55.16M | 31.93% |
Net na kita | -3.79M | -4,560.00% |
Net profit margin | -3.12 | -3,566.67% |
Kita sa bawat share | -0.02 | — |
EBITDA | 18.41M | 10.98% |
Aktuwal na % ng binabayarang buwis | -97.76% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 118.14M | -31.44% |
Kabuuang asset | 1.05B | 8.97% |
Kabuuang sagutin | 281.78M | 49.58% |
Kabuuang equity | 766.79M | — |
Natitirang share | 99.29M | — |
Presyo para makapag-book | 0.80 | — |
Return on assets | 0.15% | — |
Return on capital | 0.19% | — |
Cash Flow
Net change in cash
| (CAD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -3.79M | -4,560.00% |
Cash mula sa mga operasyon | 10.16M | 102.61% |
Cash mula sa pag-invest | -1.41M | -112.20% |
Cash mula sa financing | -5.91M | -50.47% |
Net change in cash | 4.06M | -68.64% |
Malayang cash flow | -3.92M | -484.53% |
Tungkol
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Itinatag
2014
Headquarters
Website
Mga Empleyado
745
